XML 98 R78.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 7 - Impairments - Asset Impairment Charges (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Impairment of marketable securities and other investments* (5) [1],[2] $ 9,800 $ 4,800
Impairment charges 93,266 45,464 217,858
Cumulative foreign currency translation loss included in discontinued operations (6) [3] 92,900
Income tax benefit (72,545) (60,230) (22,438)
Net [Member]      
Impairment charges 71,800 30,900 209,600
Noncontrolling Interest [Member]      
Noncontrolling interests (400) (5,600) (400)
Discontinued Operations [Member]      
Impairment charges   100  
Income tax benefit (1,700)
Operating Expense [Member]      
Impairment charges 93,300 45,400 39,800
Impairment Charges [Member]      
Income tax benefit (21,100) (9,000) (6,100)
Other Real Estate Investments [Member]      
Real estate [2],[4] 5,300 1,700
Real estate [2],[4] 5,300 1,700
Property Carrying Values [Member]      
Real estate [2],[5],[6],[7] 93,300 30,300 33,300
Real estate [2],[5],[6],[7] 93,300 30,300 33,300
Property Carrying Values [Member] | Discontinued Operations [Member]      
Real estate [8] 100 85,100
Real estate [8] $ 100 $ 85,100
[1] During 2015 and 2014, the Company reviewed the underlying cause of the decline in value of certain cost method investments, as well as the severity and the duration of the decline and determined that the decline was other-than-temporary. Impairment charges were recognized based upon the calculation of the investments' estimated fair value.
[2] See Footnote 16 of the Notes to Consolidated Financial Statements for additional disclosure on fair value
[3] Due to the substantial liquidation of its investment in Mexico, the Company recognized a loss from foreign currency translation related to consolidated properties in the amount of $92.9 million, before noncontrolling interest of $5.8 million.
[4] Impairment charges primarily based upon review of residual values, sales prices and debt maturity status and the likelihood of foreclosure of certain underlying properties within the Company's preferred equity investments, during 2015 and 2014. The Company believes it will not recover its investment in certain preferred equity investments and as such recorded full impairments on these investments.
[5] During 2014, the Company recognized aggregate impairment charges of $33.3 million, before an income tax benefit of $6.1 million and noncontrolling interests of $0.3 million.
[6] During 2015, the Company recognized aggregate impairment charges of $30.3 million, before an income tax benefit of $5.4 million and noncontrolling interests of $5.6 million.
[7] During 2016, the Company recognized aggregate impairment charges of $93.3 million, before an income tax benefit of $21.1 million and noncontrolling interests of $0.4 million, primarily related to sale of certain operating properties, certain properties maintained in the Company's TRS for which the hold period was re-evaluated in connection with the Merger (see Footnote 22 of the Notes to Consolidated Financial Statements for additional disclosure) and adjustments to property carrying values in connection with the Company's efforts to market certain properties and management's assessment as to the likelihood and timing of such potential transactions and the anticipated hold period for such properties.
[8] See Footnotes 5 & 6 of the Notes to Consolidated Financial Statements above for additional disclosure